Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies

Similar documents
Left Ventricular Assist Devices LVAD. North Country EMS Program Agency 3/21/12

EMS: Care of the VAD Patient. Brittany Butzler BSN RN VAD Coordinator Froedtert and the Medical College of WI

Ventricular Assisting Devices in the Cathlab. Unrestricted

1/21/2016. HeartMate II Indications for Use. Ventricular Assist Device Overview. Jon G. Echterling MSN, CCRN, FNP-BC. Learning Objectives

Destination Therapy SO MUCH DATA IN SUCH A SMALL DEVICE. HeartWare HVAD System The ONLY intrapericardial VAD approved for DT.

07/17/2014. Thursday, July 17, 14

McHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Continuing Education Packet January-Feb 2018 Ventricular Assist Devices

EMS and Nursing Considerations in VAD Patient Care

UNIVERSITY OF UTAH HEALTH CARE HOSPITALS AND CLINICS

STATE OF OKLAHOMA 2014 EMERGENCY MEDICAL SERVICES PROTOCOLS

Left Ventricular Assist Devices (LVADs): Overview and Future Directions

Mechanical Support in the Failing Fontan-Kreutzer

Giving your heart strength. Ventricular Assist Device.

Facts. STRONG Risk Factors for HF* LVAD, BiVAD, RVAD, HVAD 10/21/ million adults in the US have heart failure.

VAD Program Alert: Practice Change regarding CPR

Ventricular Assist Devices for Permanent Therapy: Current Status and Future

The Counter HF Clinical Study for Heart Failure

FEATURE. 58 EMERGENCY MEDICINE I FEBRUARY

Curtin University is a trademark of Curtin University of Technology CRICOS Provider Code 00301J

Tri-City Cardiology Consultants FIFTH ANNUAL SYMPOSIUM

Hardware in the Chest - From VADs to Valves

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research

QUICK REFERENCE HEARTWARE HVAD PUMP FLOW INDEX

CHANGING THE WAY HEART FAILURE IS TREATED. VAD Therapy

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know!

Perioperative Management of the Mechanical Circulatory Support Patient. American Association of Thoracic Surgeons Allied Health Symposium May 4, 2013

DEMYSTIFYING VADs. Nicolle Choquette RN MN Athabasca University

Ventricular Assist Device (VAD)

Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) Long Term Outcomes

Left Ventricular Assist Device: What Should I Report?

เอกราช อร ยะช ยพาณ ชย

Understanding the Pediatric Ventricular Assist Device

About Your Ventricular Assist Device (VAD) Surgery

Diagnosis of Device Thrombosis

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

Echo in Heart Failure

HeartWare ADVANCE Bridge to Transplant Trial and Continued Access Protocol Update

From Recovery to Transplant: One Patient's Journey

Ventricular Assist Devices

LIVING A MORE ACTIVE LIFE. with the HeartMate 3 LVAD for the treatment of advanced heart failure RON. Recipient

HEARTWARE HVAD WAVEFORM APP INSTRUCTIONS

Ventricular Assist Device. Lauren Bartlett 10/5/16 BME 281, section 1

MEDICAL POLICY Ventricular Assist Devices

Make you feel better Make you live longer

ORIGINAL ARTICLE. Alexander M. Bernhardt a, *, Theo M.M.H. De By b, Hermann Reichenspurner a and Tobias Deuse a. Abstract INTRODUCTION

Assist Devices in STEMI- Intra-aortic Balloon Pump

Overview of MCS in Bruce B Reid, MD Surgical Director Artificial Heart Program/Heart Transplantation

The Balancing Act Bleeding and Thrombosis in MCS. Muhammad Adil Soofi

3/1/2017. Chronic Mechanical Support for Heart Failure. Heart Failure is a major driver of morbidity and mortality in the US 1-7

Is it time to consider a HEARTMATE LEFT VENTRICULAR ASSIST DEVICE (LVAD)?

Implantable Ventricular Assist Devices and Total Artificial Hearts. Policy Specific Section: June 13, 1997 March 29, 2013

Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation

Cardiogenic Shock in Acute MI

Mechanical Circulatory Support in the Management of Heart Failure

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize

Cath Lab Essentials : LV Assist Devices for Hemodynamic Support (IABP, Impella, Tandem Heart, ECMO)

Outpatient Treatment of MCS Patient. F. Bennett Pearce, MD Professor of Pediatrics Med Director Heart Transplant COA

Focused. se with 2008 F. lar Heart Diseas. date. ents With Valvul. Upd. gement of Patie. lines for Manag. HA 2006 Guidel ACC/AH. Fig.

AUTOLOGS TM ATLAS ON DEMAND DATA WITH EVERY PATIENT VISIT

Artificial Heart Program

First Experiences With the HeartWare Ventricular Assist System in Children

LVAD Complications, Recovery

12/19/2017. Learning Objectives. Mechanical Circulatory Support. Mechanical Aids to External Massage. Noninvasive Mechanical Support Devices

Policy Specific Section: May 16, 1984 April 9, 2014

ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012

Heart Failure Medical and Surgical Treatment

Section 6 Intra Aortic Balloon Pump

New Trends and Indications for LVADs

CVAD COMPARISON OF VENTRICULAR ASSIST DEVICES. Background

Disclosures. No disclosures to report

Surgical Options for Advanced Heart Failure

Risk Factors for Adverse Outcome after HeartMate II Jennifer Cowger, MD, MS St. Vincent Heart Center of Indiana

Device Therapy for Heart Failure

Mechanical Cardiac Support and Cardiac Transplant: The Role for Echocardiography

UC Irvine Journal of Education and Teaching in Emergency Medicine

Rhondalyn C. McLean. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume VII, A. Study Purpose and Rationale

Amyloidosis and the Heart

Minimally invasive left ventricular assist device placement

Medical Therapy after LVAD

Advances in Advanced Heart Failure Therapies. Disclosures. Management Algorithm for Patients in Cardiogenic Shock

PROVEN. TRUSTED. COMMITTED. HeartWare HVAD System

Total Artificial Hearts and Implantable Ventricular Assist Devices

Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio

Extra Corporeal Life Support for Acute Heart failure

Innovation therapy in Heart Failure

Do we really need an Artificial Heart? No!! John V. Conte, MD, Professor of Surgery Johns Hopkins University School of Medicine

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Which mechanical assistance for cardiogenic shock?

Percutaneous Mechanical Circulatory Support Devices

VENTRICULAR ASSIST DEVICES AND TOTAL ARTIFICIAL HEARTS

Further devices to treat heart failure

Heart failure is the final common

Name of Policy: Ventricular Assist Devices and Total Artificial Hearts

State-of-the-Art Management of Chronic Systolic Heart Failure

None. Declaration of conflict of interest

Introducing the COAPT Trial

9/30/15. Epidemiology. Management of Left Ventricular Assist Devices in Heart Failure Patients. Jennifer Mazzoni, DO FACC. I have no disclosures

Mechanics of Cath Lab Support Devices

End Stage Heart Failure - Time to Bring the Hammer Down

Transcription:

Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies ERIC T. ROME D.O. HEART FAILURE, MECHANICAL ASSISTANCE AND TRANSPLANTATION CVI

Left Ventricular Assist Device An LVAD is a pump that is connected to the left ventricular at, or near the apex and to the ascending aorta. It continuously pumps blood from the left ventricle to the rest of the body.

Left Ventricular Assist Device What are LVADs used for? They are used as adjunctive therapy for end stage heart failure. Are there different types of LVAD Patients? At time of implantation, LVAD patients are classified as either: Bridge to Transplant: These patients are currently listed for a heart transplantation, and we have determined they require an LVAD as a bridge-to-transplant. Destination Therapy: These patients do not qualify for heart transplantation at the time of their evaluation. Many patients become eligible for transplantation, and go on to transplantation. Others have medical or social issues that preclude them from transplantation and they will have the LVAD for the rest of their life.

Who qualifies a patient to receive an LVAD? For Bridge to Transplant Therapy Patients Must: Be on the list to receive a heart transplant For Destination Therapy Patients Must (Per Medicare Guidelines): Have chronic end-stage heart failure (NYHA Class IV) who are not candidates for heart transplantation at the time of VAD implant, and meet the following conditions: Have failed to respond to optimal medical management (including beta-blockers and ACE inhibitors if tolerated) for 45 of the last 60 days, or have been balloon pump-dependent for 7 days, or IV inotrope-dependent for 14 days; and, Have a left ventricular ejection fraction (LVEF) < 25%; and, Have demonstrated functional limitation with a peak oxygen consumption of 14 ml/kg/min unless balloon pump or inotrope dependent or physically unable to perform the test.

Left Ventricular Assist Device (LVAD) What are the Contraindications? Inability to tolerate anticoagulation Other considerations: Co-morbid conditions Right ventricular function Nonreversible end organ failure Surgical limitations Need for additional cardiac surgical procedures (valve replacement or repair) Acceptance of blood products Pregnancy Social support Financial support

LEFT VENTRICULAR ASSIST DEVICE Most of the LVAD is implanted inside the body, except the percutanous lead that exits the body in the lower abdomen. This lead is used to connect the pump to the system controller and a power source.

Types of LVADs HeartWare HeartMate 3

Axial Flow vs Centrifugal Flow Pumps Axial Flow HeartMate II Centrifugal Flow HeartMate 3 HeartWare

Left Ventricular Assist Device (LVAD) All three of these LVADs follow a few of the same design concepts. Rotor/Impeller is the only moving part Increases device longevity No Valves Because they do not contain valves, there is a potential for forward and backward flow through the pump Flow through the pump increases and decreases based on the native LV

LVAD Basics An LVAD is preload dependent; that mean there needs to be enough blood coming to the LVAD. Therefore two main factors that affect preload: Volume status Right ventricular function The pump is also affected by afterload, so any increase in the blood pressure cause the LVAD to consume more power and decreases the LVAD flow and its effectiveness.

The Equipment

HeartMate II/HeartMate 3

System Controller HeartMate II HeartMate 3

HeartWare (HVAD)

HeartWare Controller

Potential Complications Hypovolemia Arrhythmia Thromboembolism Infection Bleeding Neurological dysfunction Psycho-social issues Device Issues

LVAD Patient Assessment What should I assess when I see LVAD patients? Pump function Is the pump running? Pump parameters Percutaneous lead connected to system controller and percutaneous lead lock in locked position Exit site status, immobilization of percutaneous lead Vital signs including mean pressure System circulation Mental status, level of consciousness Weight trend, edema, signs and symptoms of heart failure Lab work

Patient Assessment Vital Signs No pulse Left ventricle does not have enough volume to open aortic valve during systole Blood pressure Cannot use automatic blood pressure machine Doppler used to get mean arterial pressure Target mean pressure of 70-90 mmhg

LVAD : Anticoagulation Regimens All LVAD patient s are anticoagulated due to the risk of clot formation in pump Warfarin with goal of 2 to 3 Aspirin 81 mg daily Dipyridamole 75 mg tid for 90 days (HeartMate II only) No vitamin K FFP

LVAD Pump Thrombosis

Warnings & Restrictions No excessive jumping or contact sports No swimming No exposure to MRI Avoid strong static discharge (i.e. TV, computer screens, vacuuming carpets) No pregnancy

Emergency Care What happens if the pump stops? Most patients have some residual LV function and may maintain an adequate blood pressure. They may quickly develop cardiogenic shock. If minimal LV function, regurgitate flow will cause LV to dilate which is often fatal. Need to restart pump within 10-15 minutes or the pump can not be restarted Call the LVAD call phone for emergencies

Emergency Care What would cause the pump to stop? Depleted Batteries Loss of home power and not switched to battery Controller Failure Redundant System Driveline Fracture Pump Failure

Emergency Care Cardiopulmonary Resuscitation No CPR This may dislodge inflow or outflow cannula resulting in hemorrhage May perform cardioversion or defibrillation as needed. This will not effect the LVAD or controller. May give ACLS medications as per ACLS protocol

Emergency Care Routing of Patients Must send patient to Nebraska Medicine or to local ED for stabilization then transfer to Nebraska Medicine Other centers will not be able to treat pump related issues

Survival